TNDM
Tandem Diabetes Care, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$19.90
−2.59%Aug 6, 2026, 20:05 UTC
Tandem Diabetes Care reported its financial results for the quarter ended June 30, 2026, with worldwide sales of $254.6 million and gross margin of 57%.
Jul 1, 2026, 12:30 UTC
Tandem Diabetes Care launched t:slim X2 insulin pump compatibility with Abbott FreeStyle Libre 3 Plus sensor in five EU countries.
Source:Jun 5, 2026, 12:30 UTC
Tandem Diabetes Care received CE mark approval for its automated insulin delivery systems for use in type 1 diabetes during pregnancy and adults with type 2 diabetes in Europe.
Source: